Lacrivera Versus BVI Punctal Plugs in Management of Dry Eye

Overview

About this study

The purpose of this study is to compare the retention rates of Lacrivera and BVI punctal plugs over a 6-month period in patients with dry eye syndrome.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults diagnosed with dry eye syndrome
  • Clinically assessed and determined to require punctal occlusion for the management of ocular surface disease

Exclusion Criteria:

  • Patients needing only a single punctum occluded

 Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/18/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Barbara Tylka, O.D.

Open for enrollment

Contact information:

Emily Treichel

(507) 284-8558

Treichel.Emily@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20577100

Mayo Clinic Footer